Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
11,735,030
-
Shares change
-
+43,468
-
Total reported value, excl. options
-
$18,894,000
-
Value change
-
+$69,173
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$1.61
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q4 2018
12 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q4 2018.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,735,030 shares
of 139,295,316 outstanding shares and own 8.42% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (9,207,012 shares), Park West Asset Management LLC (1,258,733 shares), Telemetry Investments, L.L.C. (796,826 shares), Vanguard Group Inc (337,564 shares), RENAISSANCE TECHNOLOGIES LLC (56,048 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (50,000 shares), MORGAN STANLEY (10,824 shares), BlackRock Inc. (10,306 shares), BANK OF AMERICA CORP /DE/ (4,572 shares), and UBS Group AG (1,887 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.